IBRX — Immunitybio Balance Sheet
0.000.00%
Last trade - 00:00
- $4.95bn
- $5.53bn
- $0.62m
- 11
- 11
- 100
- 36
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-Q | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 51.7 | 96.1 | 317 | 107 | 266 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.303 | 4.99 | 1.33 | 1.89 | 3.17 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 55.8 | 112 | 334 | 141 | 294 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 72.2 | 90.7 | 119 | 190 | 183 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 143 | 221 | 469 | 362 | 504 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 11.6 | 68.1 | 369 | 501 | 58.3 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 22.4 | 341 | 711 | 810 | 1,091 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 121 | -120 | -242 | -447 | -587 |
Total Liabilities & Shareholders' Equity | 143 | 221 | 469 | 362 | 504 |
Total Common Shares Outstanding |